WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
COUNTRY GARDEN (02007) issued a total of approximately 222 million shares through the conversion of zero-coupon mandatory convertible bonds.
The listing status of Zhejiang Yongan (08211) will be canceled starting from March 16th.
Jiangsu Asia-Pacific Light Alloy Technology's subsidiary, Yaha Technology, has been awarded the national-level Green Factory for the year 2025.
COUNTRY GARDEN (02007) issued a total of approximately 222 million shares through the conversion of zero-coupon mandatory convertible bonds.
The listing status of Zhejiang Yongan (08211) will be canceled starting from March 16th.
Jiangsu Asia-Pacific Light Alloy Technology's subsidiary, Yaha Technology, has been awarded the national-level Green Factory for the year 2025.
RECOMMEND
“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
11/03/2026
Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
11/03/2026
U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
11/03/2026
